J Meyer, MD
Pain Medicine · Grand Island, NENPI 1386630283
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Medtronic at 49.3% of the total. Reporting peaked in 2019 at $731 and has fallen 97.6% since, to $17 in 2025. That places this record below the midpoint for pain medicine clinicians in NE, where the typical reported total is $4,468.
Across 82 payments — averaging $22.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$915
- Abbott$244
- Collegium Pharmaceutical, Inc.$137
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$123
- AbbVie$77
- Tersera Therapeutics LLC$53
- plus $307 from 12 others
What the payments were for
- Food & beverage$1,856100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 42 | $915 |
| Abbott | 5 | $244 |
| Collegium Pharmaceutical, Inc. | 9 | $137 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $123 |
| AbbVie | 3 | $77 |
| Tersera Therapeutics LLC | 3 | $53 |
| Forte Bio-pharma LLC | 1 | $37 |
| Lilly USA, LLC | 2 | $36 |
| Si-bone, Inc. | 1 | $33 |
| Boston Scientific | 2 | $31 |
| Pfizer | 2 | $25 |
| SPR Therapeutics, Inc | 1 | $24 |
| Biodelivery Sciences International, Inc. | 2 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Relievant Medsystems, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$113
How this compares
$1,856 in reported general payments places this provider in the 30th percentile of 31 pain medicine providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 80 | $32,789 |
| Xtampza ErOxycodone Myristate | 45 | $28,381 |
| Fentanyl | 102 | $13,104 |
| BelbucaBuprenorphine Hcl | 15 | $12,228 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 305 | $10,192 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 249 | $6,837 |
| MovantikNaloxegol Oxalate | 15 | $6,251 |
| Morphine Sulfate ErMorphine Sulfate | 199 | $4,995 |
| Gabapentin | 146 | $2,701 |
| Pregabalin | 73 | $1,757 |
| Tizanidine Hcl | 119 | $1,303 |
| Tramadol Hcl | 107 | $1,098 |
| Baclofen | 35 | $723 |
| Oxycodone Hcl | 45 | $673 |
| Hydromorphone Hcl | 23 | $516 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $137 | $40,60960 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 31 pain medicine providers in Nebraska.
Other pain medicine in Grand Island
- Dongyup LeeGrand Island$11K
- Bradley SingerGrand Island$7K
- Phillip EssayLincoln$63K
- Austin ReillyElkhorn$34K
- Charles WhittenLincoln$25K
- Matthew StottleOmaha$14K
- John MasseyLincoln$13K
- Liane DonovanLincoln$13K
- Katie BerkyOmaha$12K
- Ihsan BalkayaNorfolk$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.